Considering the different situation between FGF19 and FGF21 in the present and previous studies, we suggest that reduced serum FGF19 levels could be involved in the pathophysiology of GDM and GDM associated complications, while increased serum FGF21 levels could be in a compensatory response to this disease. The gene discussed is FGF21; the disease is gestational diabetes.